Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 65, Issue 4, pp. 1541-1546
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 5, 2003
- Revision received June 7, 2004
- Accepted December 1, 2004
- Published first February 25, 2005.
Copyright & Usage
©2005 American Association for Cancer Research.
Author Information
- Yoichi Nakamura1,
- Mikio Oka2,
- Hiroshi Soda1,
- Ken Shiozawa1,
- Megumi Yoshikawa3,
- Akiko Itoh3,
- Yoji Ikegami3,
- Junji Tsurutani1,
- Katsumi Nakatomi1,
- Takeshi Kitazaki1,
- Seiji Doi1,
- Hisahiro Yoshida3, and
- Shigeru Kohno1
- 1Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan; 2Division of Respiratory Medicine, Department of Internal Medicine, Kawasaki Medical School, Kurashiki, Okayama, Japan; and 3Department of Drug Metabolism and Disposition, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan
- Requests for reprints:
Mikio Oka, Division of Respiratory Medicine, Department of Internal Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan. Phone: 81-86-462-1111; Fax: 81-86-464-1041; E-mail: moom{at}med.kawasaki-m.ac.jp.
February 2005
Volume 65, Issue 4
Volume 65, Issue 4
Gefitinib (“Iressa”, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses Breast Cancer Resistance Protein/ABCG2–Mediated Drug Resistance
Jump to section
Advertisement